President-elect Donald Trump has announced the nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS), a decision that has triggered a wide range of reactions across the political and scientific communities. Kennedy, known for his advocacy on food safety and his criticism of the pharmaceutical industry, has stated his primary goal will be to address the 'chronic disease epidemic' in the United States. Supporters of the move suggest that Kennedy’s outsider perspective could lead to much-needed transparency and reform within federal health agencies. However, critics and public health officials have raised concerns, citing his history of skepticism regarding vaccine safety and established medical consensus. If confirmed by the Senate, Kennedy would oversee a massive department including the CDC, FDA, and NIH. Lawmakers are expected to conduct rigorous confirmation hearings to examine how his proposed policies might impact national health security and regulatory standards.